146 related articles for article (PubMed ID: 17301571)
1. HIV-1 natural viral suppressors: control of viral replication in the absence of therapy.
Sajadi MM; Heredia A; Le N; Constantine NT; Redfield RR
AIDS; 2007 Feb; 21(4):517-9. PubMed ID: 17301571
[TBL] [Abstract][Full Text] [Related]
2. Few modifications of the Cobas Amplicor HIV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells.
Lillo FB; Grasso MA; Lodini S; Bellotti MG; Colucci G
J Virol Methods; 2004 Sep; 120(2):201-5. PubMed ID: 15288963
[TBL] [Abstract][Full Text] [Related]
3. Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens.
Sarmati L; Parisi SG; Nicastri E; d'Ettorre G; Andreoni C; Dori L; Gatti F; Montano M; Buonomini AR; Boldrin C; Palù G; Vullo V; Andreoni M
J Med Virol; 2007 Jul; 79(7):880-6. PubMed ID: 17516532
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
5. Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infection.
Novitsky VA; Gilbert PB; Shea K; McLane MF; Rybak N; Klein I; Thior I; Ndung'u T; Lee TH; Essex ME
Virology; 2006 May; 349(1):142-55. PubMed ID: 16519915
[TBL] [Abstract][Full Text] [Related]
6. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
7. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells.
Ondoa P; Davis D; Kestens L; Vereecken C; Garcìa Ribas S; Fransen K; Heeney J; van der Groen G
J Med Virol; 2002 Jul; 67(3):301-11. PubMed ID: 12116019
[TBL] [Abstract][Full Text] [Related]
9. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
[TBL] [Abstract][Full Text] [Related]
10. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
[TBL] [Abstract][Full Text] [Related]
11. Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia.
McDermott JL; Martini I; Ferrari D; Bertolotti F; Giacomazzi C; Murdaca G; Puppo F; Indiveri F; Varnier OE
J Clin Microbiol; 2005 Oct; 43(10):5272-4. PubMed ID: 16207994
[TBL] [Abstract][Full Text] [Related]
12. Differences in proviral DNA load between HIV-1- and HIV-2-infected patients.
Gueudin M; Damond F; Braun J; Taïeb A; Lemée V; Plantier JC; Chêne G; Matheron S; Brun-Vézinet F; Simon F
AIDS; 2008 Jan; 22(2):211-5. PubMed ID: 18097223
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?
Goujard C; Chaix ML; Lambotte O; Deveau C; Sinet M; Guergnon J; Courgnaud V; Rouzioux C; Delfraissy JF; Venet A; Meyer L;
Clin Infect Dis; 2009 Sep; 49(6):982-6. PubMed ID: 19681706
[TBL] [Abstract][Full Text] [Related]
14. Control of HIV-1 RNA load after HAART interruption: relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients.
Soriano-Sarabia N; Vallejo A; Fernández G; Genebat M; Gutiérrez S; Muñoz-Fernández MA; Leal M
J Clin Virol; 2007 Sep; 40(1):64-7. PubMed ID: 17662650
[TBL] [Abstract][Full Text] [Related]
15. Natural control of HIV-1 replication and long-term nonprogression: overlapping but distinct phenotypes.
Hunt PW
J Infect Dis; 2009 Dec; 200(11):1636-8. PubMed ID: 19852668
[No Abstract] [Full Text] [Related]
16. Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.
Pomerantz RJ
Arch Immunol Ther Exp (Warsz); 2004; 52(5):297-306. PubMed ID: 15507870
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of HIV-1 subtype B' isolates from infected Chinese blood donors at different disease stages.
Chen Y; Shen C; Wu H; Caruso L; Ratner D; Rodriguez M; Chen X; Gupta P
Virology; 2009 Feb; 384(1):161-8. PubMed ID: 19058828
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
19. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
20. Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml.
Kupfer B; Matz B; Däumer MP; Roden F; Rockstroh JK; Qurishi N; Spengler U; Kaiser R
J Med Virol; 2007 Oct; 79(10):1440-5. PubMed ID: 17705170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
